Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Chase

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Biorxiv : the Preprint Server for Biology|April 24, 2023
High-throughput phenogenotyping <i>of Mycobacteria tuberculosis</i> clinical strains reveals bacterial determinants of treatment outcomesSydney Stanley, Caitlin N Spaulding, Qingyun Liu, et al.
The Lancet. Microbe|May 11, 2024
Identification of bacterial determinants of tuberculosis infection and treatment outcomes: a phenogenomic analysis of clinical strainsSydney Stanley, Caitlin N Spaulding, Qingyun Liu, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
CD4 T cells and CD8α+ lymphocytes are necessary for intravenous BCG-induced protection against tuberculosis in macaquesAndrew W Simonson, Joseph J Zeppa, Allison N Bucsan, et al.
The Journal of Experimental Medicine|February 6, 2025
Intravenous BCG-mediated protection against tuberculosis requires CD4+ T cells and CD8α+ lymphocytesAndrew W Simonson, Joseph J Zeppa, Allison N Bucsan, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Biorxiv : the Preprint Server for Biology|April 24, 2023
High-throughput phenogenotyping <i>of Mycobacteria tuberculosis</i> clinical strains reveals bacterial determinants of treatment outcomesSydney Stanley, Caitlin N Spaulding, Qingyun Liu, et al.
The Lancet. Microbe|May 11, 2024
Identification of bacterial determinants of tuberculosis infection and treatment outcomes: a phenogenomic analysis of clinical strainsSydney Stanley, Caitlin N Spaulding, Qingyun Liu, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
CD4 T cells and CD8α+ lymphocytes are necessary for intravenous BCG-induced protection against tuberculosis in macaquesAndrew W Simonson, Joseph J Zeppa, Allison N Bucsan, et al.
The Journal of Experimental Medicine|February 6, 2025
Intravenous BCG-mediated protection against tuberculosis requires CD4+ T cells and CD8α+ lymphocytesAndrew W Simonson, Joseph J Zeppa, Allison N Bucsan, et al.
Pageof 4